Literature DB >> 19582404

The paradoxical cell biology of alpha-Synucle.

Subhojit Roy1.   

Abstract

Synucleinopathies are a group of neurodegenerative diseases characterized by accumulation and aggregation of the protein alpha-synuclein in neuronal perikarya and processes. In contrast to the proximal localization of alpha-synuclein in diseased states, under physiologic conditions, the bulk of alpha-synuclein is present in distant presynaptic terminals. Thus, pathologic conditions lead to mislocalization and aggregation of alpha-synuclein in neuronal cell bodies, and an outstanding question relates to the cell-biological mechanisms that can lead to such mislocalization. Like most other synaptic proteins, alpha-synuclein is synthesized in the neuronal perikarya and then transported into axons and synaptic domains. Accordingly, it has been hypothesized that disturbances in biogenesis/axonal transport or presynaptic targeting of alpha-synuclein can lead to its mislocalization in diseased states. In this chapter, key observations that lead to this hypothesis are presented in addition to a review of some recent literature that has directly addressed this issue. Finally, conflicting results that have resulted from such studies are also highlighted, and a view is offered to reconcile these controversies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582404     DOI: 10.1007/400_2009_23

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN: 0080-1844


  8 in total

1.  Reduced hypocretin (orexin) levels in dementia with Lewy bodies.

Authors:  Stephanie Lessig; Kiren Ubhi; Douglas Galasko; Anthony Adame; Emiley Pham; Kelly Remidios; Michael Chang; Lawrence A Hansen; Eliezer Masliah
Journal:  Neuroreport       Date:  2010-08-04       Impact factor: 1.837

Review 2.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

3.  The slow axonal transport of alpha-synuclein--mechanistic commonalities amongst diverse cytosolic cargoes.

Authors:  Yong Tang; Utpal Das; David A Scott; Subhojit Roy
Journal:  Cytoskeleton (Hoboken)       Date:  2012-03-02

4.  Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors.

Authors:  Gabriel Gustafsson; Fredrik Eriksson; Christer Möller; Tomás Lopes da Fonseca; Tiago F Outeiro; Lars Lannfelt; Joakim Bergström; Martin Ingelsson
Journal:  Cell Mol Neurobiol       Date:  2016-03-10       Impact factor: 5.046

5.  A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration.

Authors:  David A Scott; Iustin Tabarean; Yong Tang; Anna Cartier; Eliezer Masliah; Subhojit Roy
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

6.  Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Authors:  Dora Games; Peter Seubert; Edward Rockenstein; Christina Patrick; Margarita Trejo; Kiren Ubhi; Benjamin Ettle; Majid Ghassemiam; Robin Barbour; Dale Schenk; Silke Nuber; Eliezer Masliah
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

7.  Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases.

Authors:  Irene Sambri; Rosa D'Alessio; Yulia Ezhova; Teresa Giuliano; Nicolina Cristina Sorrentino; Vincenzo Cacace; Maria De Risi; Mauro Cataldi; Lucio Annunziato; Elvira De Leonibus; Alessandro Fraldi
Journal:  EMBO Mol Med       Date:  2017-01       Impact factor: 12.137

8.  The Non-amyloidal Component Region of α-Synuclein Is Important for α-Synuclein Transport Within Axons.

Authors:  Eric N Anderson; Delnessaw Hirpa; Kan Hong Zheng; Rupkatha Banerjee; Shermali Gunawardena
Journal:  Front Cell Neurosci       Date:  2020-01-10       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.